Audio Categories: News

MondayJan 11, 2021 8:50 am

NetworkNewsAudio – Ideanomics (NASDAQ: IDEX) Signs Definitive Agreement to Acquire Leading Provider of Wireless Charging Systems for Commercial EVs

Related Press Release Ideanomics (NASDAQ: IDEX) announced it has signed a definitive agreement to acquire 100% of privately held Wireless Advanced Vehicle Electrification, Inc. ("WAVE") for cash and stock consideration, the material terms of which are disclosed in the Company's related 8-K filing. Roth Capital Partners acted as an advisor to WAVE on the transaction. The acquisition is subject to customary closing conditions. To view the original press release, visit https://www.nnw.fm/TmFix About Ideanomics Ideanomics is a global company focused on the convergence of financial services and industries experiencing technological disruption. Our Mobile Energy Global (MEG) division is a service provider…

Continue Reading

MondayJan 04, 2021 7:00 am

NetworkNewsAudio – Ideanomics (NASDAQ: IDEX) Division Announces Purchase Agreement for 2,000 Units of D1, BYD’s Custom Electric Ride-hailing Vehicle

Related Press Release Ideanomics (NASDAQ: IDEX) announced that its Mobile Energy Global ("MEG") and its contracting entity Qingdao Chengyang Medici have signed an agreement with Meihao Chuxing, a joint venture between BYD and Didi, to purchase an initial 2,000 units of model BYD D1. The ride-hailing vehicles are intended for deployment in multiple cities within China, with deliveries expected to begin in H1 2021. To view the original press release, visit https://www.nnw.fm/HOTb3 About Ideanomics Ideanomics is a global company focused on the convergence of financial services and industries experiencing technological disruption. Our Mobile Energy Global (MEG) division is a service…

Continue Reading

MondayDec 28, 2020 8:00 am

NetworkNewsAudio – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces FDA Approval of IND Application for its Brain Cancer Drug Candidate Berubicin

Related Press Release CNS Pharmaceuticals (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that the Investigational New Drug (IND) application for its lead product candidate, Berubicin, for the treatment of Glioblastoma Multiforme (GBM) is now approved and in effect as filed with the US Food and Drug Administration (FDA). The Company will initiate its trial during the first quarter of 2021 to investigate the efficacy of Berubicin in adults with GBM who have failed first-line therapy.  Recent correspondence…

Continue Reading

FridayDec 18, 2020 8:30 am

NetworkNewsAudio – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Aims to Revitalize Rare Earth Element Production in the U.S.

Related Editorial The United States was once a thriving producer of rare earth elements ("REEs"), a group of 17 elements deemed critical to clean energy and modern technologies. REEs are used in a bevy of applications including cell phones, computers, electric vehicles, defense equipment, renewable energy systems and more. China has dominated global rare earth markets, driving out competitors and controlling nearly all of the world’s processing capacity. China has wielded this monopoly of the REE supply chain to influence foreign policies, a weaponization that threatens the economic and national security of the U.S. and other countries around the world.…

Continue Reading

FridayDec 18, 2020 8:30 am

NetworkNewsAudio – Loop Insights Inc.’s (TSX.V: MTRX) (OTCQB: RACMF) All-Inclusive Bubble Venue Technology Provides Peace of Mind for NCAA Basketball

Related Editorial The COVID-19 pandemic has reached a benchmark in the United States, topping 15 million cases as the death count exceeds 285,000. The pandemic has transformed the world in many ways, including bringing digital technologies to the forefront of a socially distanced world. In this space, Loop Insights Inc. (TSX.V: MTRX) (OTCQB: RACMF) (Profile) recently made history as the first-ever, end-to-end venue-tracing and management solution. A provider of contactless solutions and artificial intelligence aimed at driving automated marketing, venue management and tracing to the brick-and-mortar space, Loop gained national attention for its “bubble,” which allowed NCAA basketball to play…

Continue Reading

FridayDec 18, 2020 8:30 am

NetworkNewsAudio – Cybin Inc. (NEO: CYBN) Establishing Psychedelic-based Drug Discovery Platform to Treat Mental Health Disorders

Related Editorial More than 700 million people worldwide are affected with some form of mental illness, addiction or eating disorder, representing about 13% of total disease burden. In reality, the worldwide picture is a bit murky, considering the high frequency of nondiagnosis as well as lack of treatment, even in the most developed countries. Advances in medicine to treat these conditions of the brain have been elusive, as conventional drugs that treat symptoms and not underlying causes remain the most popular. There are reasons to be optimistic about the future, though, underscored by increased research activity surrounding psychedelics. This is…

Continue Reading

FridayDec 11, 2020 8:00 am

NetworkNewsAudio – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Targets CBD Sector with Top-Quality Products

Related Editorial On election day this year, four more states voted to legalize the recreational use of cannabis, bringing the total of states that now allow recreational cannabis use to 15. This growing acceptance of cannabis, and more specifically CBD, which is now legal in all 50 states, has sparked an explosion of new CBD-infused products and brands within the consumer packaged goods ("CPG") space. Estimates about how large the legalized cannabis market may grow vary widely, but a Lido Consulting report notes that the total addressable cannabis market ("TAM") could potentially hit $1 trillion in global economic impact by…

Continue Reading

ThursdayDec 10, 2020 8:30 am

NetworkNewsAudio – Clean Power Capital Corp. (CSE: MOVE) (FWB: 2K6A) (OTC: MOTNF) Subsidiary to Deploy Hydrogen Fueling Infrastructure

Related Editorial Lithium demand has soared with the advent of electric vehicles, as severe supply shortages pose a serious threat to the long-term sustainability of the Battery Electric Vehicle (“BEV”) transportation sector. However, another viable option for cleaner, cheaper and more sustainable transportation exists. Instead of battery-powered electric cars, vehicles powered with hydrogen, the most abundant resource in the universe, may be the key to truly disrupting the auto industry. The world is rapidly shifting away from the dwindling resource of fossil fuels, and hydrogen is expected to play a crucial role in slashing emissions and finally achieving sustainability. Hydrogen-powered…

Continue Reading

ThursdayDec 10, 2020 8:00 am

NetworkNewsAudio – Knightscope Inc.’s Technology Improves Existing Security Infrastructure

Related Editorial From the coronavirus pandemic to nationwide public unrest, 2020 has been a year that has inspired re-imagining public safety as the country has poignantly witnessed the challenges faced by law enforcement and security services across all verticals. The answers to some of society’s greatest problems today are not to be found simply in man power; rather, many of the answers lie in technology, like that of Knightscope Inc. (Profile), which is designed to augment and improve existing security infrastructure. Silicon Valley-based Knightscope, with its lineup of fully autonomous security robots, aligns with companies such as Palantir Technologies Inc.…

Continue Reading

TuesdayNov 24, 2020 7:45 am

NetworkNewsAudio – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces FDA Filing of IND for its Brain Cancer Drug Berubicin

Related Press Release CNS Pharmaceuticals (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that it has submitted an Investigational New Drug ("IND") application, which has been accepted for review, to the U.S. Food and Drug Administration ("FDA") for Berubicin in the treatment of Glioblastoma Multiforme ("GBM"). The Company plans to evaluate the efficacy of Berubicin in a Phase 2 Trial for adults with GBM who have failed first-line therapy and commence the trial within the first quarter of…

Continue Reading